Packer M - Search Results

1

Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.

Eichhorn EJ, Tandon PK, DiBianco R, Timmis GC, Fenster PE, Shannon J, Packer M. Eichhorn EJ, et al. Among authors: packer m. J Am Coll Cardiol. 1993 Mar 1;21(3):634-40. doi: 10.1016/0735-1097(93)90095-i. J Am Coll Cardiol. 1993. PMID: 8436744 Clinical Trial.

2

Oral vasodilator therapy for chronic heart failure: a plea for caution.

Packer M, Meller J. Packer M, et al. Am J Cardiol. 1978 Oct;42(4):686-9. doi: 10.1016/0002-9149(78)90642-2. Am J Cardiol. 1978. PMID: 358821 Review. No abstract available.

3

Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.

Packer M, Meller J, Gorlin R, Herman MV. Packer M, et al. Am J Cardiol. 1979 Aug;44(2):310-7. doi: 10.1016/0002-9149(79)90322-9. Am J Cardiol. 1979. PMID: 463769

4

The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.

Packer M. Packer M. J Am Coll Cardiol. 1992 Jul;20(1):248-54. doi: 10.1016/0735-1097(92)90167-l. J Am Coll Cardiol. 1992. PMID: 1351488

5

The effect of treatment on survival in congestive heart failure.

Pitt B, Cohn JN, Francis GS, Kostis JB, Packer M, Pfeffer MA, Swedberg K, Yusuf S. Pitt B, et al. Among authors: packer m. Clin Cardiol. 1992 May;15(5):323-9. doi: 10.1002/clc.4960150504. Clin Cardiol. 1992. PMID: 1623652 Review.

6

Long-term strategies in the management of heart failure: looking beyond ventricular function and symptoms.

Packer M. Packer M. Am J Cardiol. 1992 Jun 4;69(18):150G-154G. doi: 10.1016/0002-9149(92)91263-4. Am J Cardiol. 1992. PMID: 1626488 Review.

7

Management of patients with heart failure and angina: do coexistent diseases alter the response to cardiovascular drugs?

Packer M, Kukin ML. Packer M, et al. J Am Coll Cardiol. 1991 Mar 1;17(3):740-2. doi: 10.1016/s0735-1097(10)80193-7. J Am Coll Cardiol. 1991. PMID: 1671575 No abstract available.

8

Clinical and regulatory implications of the Cardiac Arrhythmia Suppression Trial.

Pratt CM, Brater DC, Harrell FE Jr, Kowey PR, Leier CV, Lowenthal DT, Messerli F, Packer M, Pritchett EL, Ruskin JN. Pratt CM, et al. Among authors: packer m. Am J Cardiol. 1990 Jan 1;65(1):103-5. doi: 10.1016/0002-9149(90)90034-x. Am J Cardiol. 1990. PMID: 1688479 Clinical Trial. No abstract available.

9

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al. Packer M, et al. N Engl J Med. 1991 Nov 21;325(21):1468-75. doi: 10.1056/NEJM199111213252103. N Engl J Med. 1991. PMID: 1944425 Clinical Trial.

10

Hemodynamic effects of renin inhibition by enalkiren in chronic congestive heart failure.

Neuberg GW, Kukin ML, Penn J, Medina N, Yushak M, Packer M. Neuberg GW, et al. Among authors: packer m. Am J Cardiol. 1991 Jan 1;67(1):63-6. doi: 10.1016/0002-9149(91)90101-p. Am J Cardiol. 1991. PMID: 1986506 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results